Clinical Trial Update: Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluates radiation therapy plus gefitinib or temozolomide in patients with non-small cell lung cancer and brain metastases; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Lung Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED